Intrinsic Imaging has been awarded a clinical trial to study an interventional medical device designed for the prevention of pulmonary emboli.
The US FDA has cleared the Enroute transcarotid neuroprotection system (Silk Road Medical) for marketing. The system is for use during carotid artery stenting procedures and is the first one designed to access the carotid arteries through an incision in the neck, instead of the groin. It uses a blood flow reversal system to capture pieces of the blockage dislodged during the procedure.
InspireMD has received CE mark approval for its new CGuard RX rapid exchange system for its MicroNet covered carotid stent technology. Concurrently, the company announced positive six-month follow up data from its CGuard CARENET (Carotid embolic protection study using MicroNet) trial at the LINC meeting in Leipzig, Germany.
Vascular News has learnt that the SPACE 2 (Stent-protected angioplasty in asymptomatic carotid stenosis vs. endarterectomy) study has been halted due to persistently low recruitment rates. This decision to halt SPACE 2 comes just over a year after changes were made to the study protocol in an attempt to rectify the same problem.
Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities. The ESCAPE study, published 11 February in the New England Journal of Medicine, also shows that neurointerventional surgery reduces stroke mortality by 50%.
Medtronic plc has announced that it has received US Food and Drug Administration (FDA) approval for its Pipeline Flex embolisation device. Available through a limited US launch in the coming weeks, Medtronic’s latest-generation flow diversion device represents an unrivalled advancement in large and giant brain aneurysm treatment.
A new computer programme allows interventionalists to assess blood flow in real-time while they are using flow-diverter devices to treat intracranial aneurysms, suggests a pilot study presented at the 27th annual International Symposium on Endovascular Therapy (ISET, 31 January–5 February, Hollywood, USA).
The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischaemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.
Initial experience with PulseRider (Pulsar Vascular) has shown the device to be safe and effective as an adjunct in the treatment of bifurcation aneurysms arising at the basilar apex or carotid terminus according to a report of the first three cases in the USA published in the Journal of NeuroInterventional Surgery.
Kypho-IORT (Combining intraoperative radiotherapy with kyphoplasty for treatment of spinal metastases) will test a new combination treatment that delivers radiation directly to the tumour and increases support of the spine.
Silk Road Medical’s 30 day outcomes from the ROADSTER IDE study were presented at the Late Breaking Clinical Trials Session at the 2014 Vascular InterVentional Advances (VIVA) Meeting in Las Vegas, with additional data presented at the VEITHsymposium in New York.
Researchers at the Ohio State University Wexner Medical Center are attempting to improve arm movement in stroke patients by using a transcranial magnetic stimulator (TMS) device. By using TMS to reduce brain activity on the uninjured side of the brain, researchers hope that the injured side may have a better chance of recovering.
A non-invasive, portable electrical device tested at the Hermelin Brain Tumor Center at Henry Ford Hospital along with other major medical centres around the USA, has been found to lengthen the lives of some patients suffering from glioblastoma, the most common and deadliest form of brain cancer.
Neurosurgeons at Barrow Neurological Institute have implanted the world’s first scaffolding device into the spinal cord of a patient. Performed last month, the surgery involves inserting a bioresorbable scaffolding implant to act as a bridge across the gap of the injured section of the cord in an attempt to help the spinal cord heal.
A specialised ambulance staffed with a neurologist and equipped with a computed tomographic scanner helped increase the percentage of patients with stroke who received thrombolysis to break down blood clots within the so-called ‘golden hour,’ the 60 minutes from time of symptom onset to treatment when treatment may be most effective, according to a study published online by JAMA Neurology.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos